💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Gilead Sciences, Inc. (GILD)
« Back to company indexGILD Chatter Timeline
Stock Ticker for GILD
Most Active Tweeters for GILD
| User | Tweets |
|---|---|
| @bs_marker | 22 |
| @art_isit | 20 |
| @TradeWithAlerts | 13 |
| @TWAOptions | 12 |
| @Tickeron | 9 |
Recent Tweets for GILD
 |
@PersimmonTI CAR-T Marches Forward in Treatment Line $BMY $GILD Breyanzi joins Yescarta in the second line. - will process b… https://t.co/qmQxT0spV0 June 25th 2022, 2:06pm |
 |
@art_isit $GILD -With the core HIV/hepatitis business as its backbone, Its Therapeutic candidates for blood cancer, leukemia,… https://t.co/JQRgr1rI3A June 25th 2022, 5:06am |
 |
@ALBERT81980056 $GILD Don't miss the next move in a few hours. :~ ?https://t.co/KsPWdBHgso June 25th 2022, 5:06am |
 |
@BentheFidler Bristol Myers CAR-T therapy cleared by FDA for earlier lymphoma use https://t.co/7LkmeU38Ud $GILD $NVS June 25th 2022, 12:06am |
|
@art_isit $GILD inched 0.80% higher to $63.08 today, on what proved to be an all-around favorable trading session for the st… https://t.co/tOV38umuIw June 24th 2022, 10:06pm |
 |
@bs_marker Stock: $GILD - Gilead Sciences *** NEWS *** Lilly receives positive European Medicine Agency opinion for HIV treatm… https://t.co/xEDiZXQqVK June 24th 2022, 9:06pm |
 |
@yan_blog @InvestKelo $GILD https://t.co/AVHRXTBmvX June 24th 2022, 9:06pm |
|
@bs_marker Stock: $GILD - *** REALTIME TREND *** SELL R1 = 62.90 LAST = 63.08 S1 = 62.00 Try now the Best Pivot Point Calcu… https://t.co/DuVeErKE19 June 24th 2022, 9:06pm |
|
@art_isit $GILD -announced that the CHMP of the EMA adopted a positive opinion for investigational lenacapavir for the treatm… https://t.co/utPIaIOabv June 24th 2022, 8:06pm |
 |
@dailycandlestix $GILD Hammer Daily appearances since 2010: 13 Close 5 days later ±: Avg: 1.21 SD: 2.73 Worst: -2.69 Best: 5.72 10… https://t.co/V6D5zGhxMs June 24th 2022, 8:06pm |
 |
@JSKtrade $gild volume spike https://t.co/kJ153lrn8y June 24th 2022, 7:06pm |
 |
@TradeWithAlerts Nice print for $GILD Size: 247800 Price: 62.5 Amount: $15,487,500.00 Time: 1511 See more: https://t.co/5ljLbVg3lt J… https://t.co/dO4QOtXyIi June 24th 2022, 7:06pm |
 |
@TaxHavens Commented on $GILD - Gilead receives positive European Medicine Agency opinion for HIV treatment. https://t.co/oAu4QtGLKd June 24th 2022, 5:06pm |
 |
@TWAOptions $GILD Strike: 75.00 Expiration: 2023-01-20 Call .GILD230120C75 Price: 0.73 Size: 1900 Time: 2022-06-24 1:14:08PM Premium: $138,700.00 June 24th 2022, 5:06pm |
 |
@yasiejko NEW: @GileadSciences & @LillyPad sued Natco to block copies of $GILD's Zydelig leukemia drug, alleging infringement… https://t.co/mXqYR7nerF June 24th 2022, 4:06pm |
 |
@LeeSinTrade1 $GILD $4,180 net profit 6 closed trades. 4.8 profit factor 83% win rate, buy signal in place. ? Try a Free Trial at… https://t.co/xzIlff2UFK June 24th 2022, 4:06pm |
 |
@Tickeron $GILD in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/3jFbEChbz2 June 24th 2022, 3:06pm |
 |
@OptionsMaxPain #Options #maxpain chart for $GILD. Free options app https://t.co/EQL2cBOq5n https://t.co/D50rJlDRL4 June 24th 2022, 3:06pm |
 |
@Briefingcom $ADVM $GILD https://t.co/tMt6uYkNdk June 24th 2022, 2:06pm |
|
@art_isit $GILD--In again at $62.12-- June 24th 2022, 2:06pm |
|
@art_isit $GILD -Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV Hexagon… https://t.co/U2DyfMxsiG June 24th 2022, 1:06pm |
 |
@hunter62046908 $GILD -;Top analyst price target today. https://t.co/0SG4HnWtwJ June 24th 2022, 1:06pm |
 |
@UltraStockSlay1 $GILD Look! 83% win rate 4.8 profit factor 6 close trade $4,180 net profit in a 15 minute chart and buy signal in p… https://t.co/ekTulQIpCC June 24th 2022, 1:06pm |
 |
@MarketCurrents $GILD - Lilly receives positive European Medicine Agency opinion for HIV treatment https://t.co/C8hp0ZxEKP June 24th 2022, 12:06pm |
 |
@MaiteMerenda $GILD $4,180 net profit 6 closed trades. 4.8 profit factor 83% win rate, buy signal in place. ? Begin a Free Trial… https://t.co/Qw01ZLFT5b June 24th 2022, 12:06pm |
 |
@newsfilterio Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV $GILD https://t.co/W8LnpmRjve June 24th 2022, 12:06pm |
 |
@FlashAlert_me $GILD [15s. delayed]: Issued Press Release on June 24, 08:00:00: Investigational Lenacapavir Receives Positive CHMP… https://t.co/aEICWtnVA4 June 24th 2022, 12:06pm |
 |
@HammerstoneMar3 $GILD Investigational lenacapavir receives positive chmp opinion for people with multi-drug resistant hiv Gilead Sc… https://t.co/oJkTHJfXDp June 24th 2022, 12:06pm |
 |
@StockNewsBot2 $GILD Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV https://t.co/2kNpzdlQd4 June 24th 2022, 12:06pm |
 |
@Jarvis_Alerts $GILD 67.5C Exp:20-Jan-23 -- ? Total(Day): $25,752 #UnusualActivity Sign-up free for beta ver.:… https://t.co/DD6AuCMqk4 June 24th 2022, 12:06pm |
 |
@FastestAlert $GILD Investigational Lenacapavir Receives Positive CHMP Opinion For People With Multi-Drug Resistant HIV Stock News Alerts In Bio June 24th 2022, 12:06pm |
 |
@UsMarketNews $GILD news Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV June 24th 2022, 12:06pm |
 |
@stock_titan $GILD Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV https://t.co/hofZAzo40p June 24th 2022, 12:06pm |
 |
@WebChronicleTo1 $GILD Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV https://t.co/rHNRkD32cs June 24th 2022, 12:06pm |
 |
@ShortAlgoTrades $GILD Trading Ideas | Awaiting Short signal. 100% Profitability based on 2 trades. Profit factor is 100. Learn more… https://t.co/02R7S3bKAm June 24th 2022, 11:06am |
|
@TaxHavens Commented on $GILD - Gilead Sciences, Inc. (GILD) CEO Dan O'Day Presents at Goldman Sachs Global Healthcare Confere… https://t.co/KZxysLElUd June 24th 2022, 11:06am |
|
@hunter62046908 $GILD ~'Top analyst price target today.. https://t.co/OsCHYh8F00 June 24th 2022, 10:06am |
|
@bs_marker Stock: $GILD - *** REALTIME TREND *** SELL R1 = 62.34 LAST = 62.58 S1 = 60.38 Try now the Best Pivot Point Calcu… https://t.co/bjEXdY7oEt June 24th 2022, 10:06am |
 |
@VandeveldeWim RT @Thierrry: Seems that $GILD is not fully convinced of sustainability autologous CAR-T business model. That’s… telling! June 24th 2022, 10:06am |
 |
@Thierrry Seems that $GILD is not fully convinced of sustainability autologous CAR-T business model. That’s… telling! https://t.co/8sVtLz5UZV June 24th 2022, 9:06am |
|
@bs_marker Stock: $GILD - *** REALTIME TREND *** SELL R1 = 62.34 LAST = 62.58 S1 = 60.38 Try now the Best Pivot Point Calcu… https://t.co/HnpU2ym8z8 June 24th 2022, 5:06am |
 |
@Rahul04980546 Best discord group over 80+k members and even have their own app join here https://t.co/CZvV7tzEl3 $GILD $DAL… https://t.co/q7Tx0BRfIy June 24th 2022, 4:06am |
|
@bs_marker Stock: $GILD - *** REALTIME TREND *** SELL R1 = 62.34 LAST = 62.58 S1 = 60.38 Try now the Best Pivot Point Calcu… https://t.co/BQhw6hulA2 June 24th 2022, 12:06am |
 |
@hesham_monica $GILD (NASDAQ) Technical Indicator Rating Upgraded to Sell: Gilead Sciences Inc.Ticker is 78.97% off the resistance… https://t.co/5kt04PCqz1 June 23rd 2022, 11:06pm |
|
@bs_marker Stock: $GILD - Gilead Sciences *** NEWS *** 2 Beaten-Down Dividend Stocks That Are Now Yielding 5% - Nasdaq… https://t.co/czwvB6VqIk June 23rd 2022, 9:06pm |
 |
@MarcJacksonLA $GILD Gilead trumpets win for the chronic hepatitis delta prospect it acquired in $1B+ buyout https://t.co/a5ZcNMz1jT June 23rd 2022, 9:06pm |
|
@dailycandlestix $GILD Rising Price, Declining Volume Daily appearances since 2010: 74 Close 5 days later ±: Avg: -0.04 SD: 2.40 Wor… https://t.co/hQ7kvusZm3 June 23rd 2022, 8:06pm |
 |
@SVENNIECO Gilead's chronic hepatitis delta virus drug meets main goal in Phase III study $GILD https://t.co/B9NwbZRa92 June 23rd 2022, 7:06pm |
 |
@fwpharma Gilead's chronic hepatitis delta virus drug meets main goal in Phase III study $GILD https://t.co/Li8UUSCA0z June 23rd 2022, 6:06pm |
 |
@Eroswole_ The next move under $60 should spark weakness and a nice fade. Price action is weak $GILD June 23rd 2022, 6:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.